ALT 8-K: SEC filing

Filed with the SEC on Nov 12, 2026 · accession 0001326190-26-000067

ALT filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Altimmune, Inc. furnished a Form 8-K announcing its financial results for the third quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.

For details, click here →How to read a 8-K →

Key details

RegistrantAltimmune, Inc.

Chief financial officerGregory Weaver

✦ Ask GOAX AI about this filing — what it means for ALT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ALT?

Click here

Frequently asked questions

What did ALT file with the SEC on Nov 12, 2026?

ALT filed a 8-K (SEC filing). Altimmune, Inc. furnished a Form 8-K announcing its financial results for the third quarter ended September 30, 2026, via a press release attached as Exhibit 99.1.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other ALT SEC filings

Get alerts when ALT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

ALT overview ALT analysis ALT news Latest SEC filings